Your browser doesn't support javascript.
loading
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620).
Malhotra, Monica K; Pahuja, Shalu; Kiesel, Brian F; Appleman, Leonard J; Ding, Fei; Lin, Yan; Tawbi, Hussein A; Stoller, Ronald G; Lee, James J; Belani, Chandra P; Chen, Alice P; Giranda, Vincent L; Shepherd, Stacie Peacock; Emens, Leisha A; Ivy, S Percy; Chu, Edward; Beumer, Jan H; Puhalla, Shannon.
Afiliación
  • Malhotra MK; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Pahuja S; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Kiesel BF; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Appleman LJ; Department of Pharmaceutical Sciences, School of Pharmacy, Pittsburgh, PA, USA.
  • Ding F; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Lin Y; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Tawbi HA; Biostatistics Facility, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Stoller RG; Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
  • Lee JJ; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Belani CP; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Chen AP; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Giranda VL; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Shepherd SP; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Emens LA; Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Ivy SP; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Chu E; Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA, USA.
  • Beumer JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, USA.
  • Puhalla S; Center for Cancer Research, National Cancer Institute, Bethesda, USA.
Breast Cancer Res Treat ; 198(3): 487-498, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36853577
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas / Anemia Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas / Anemia Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos